Global Licensing Partnering Terms & Agreements in Pharma, Biotech, Diagnostics 2014-2019

Current Partnering
1900+ Pages - WILD10889
$2,995.00

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.

This report provides details of the latest licensing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of licensing agreements from 2014 to 2019.

There has been a long standing willingness for parties to enter licensing deals. Such deals enable both parties to benefit from the upside of a big R&D win, whilst mitigating the risks of going it alone in the risky preclinical and clinical development stages.

Licensing is a specific type of partnering deal whereby the parties to the deal agree to commercialize a compound, product or technology.

Specifically, licensing is the granting of permission to use intellectual property rights, such as trademarks, patents, or technology, under defined conditions

There are several forms of licensing deal. Traditional licensing arrangement whereby an owner of intellectual property (the licensor) provides access to its technology to another company (the licensee) in return for agreed payments and royalties on subsequent sales of product(s) derived from the intellectual property.

In more recent times, licensing is often the outcome of a successful period of collaboration on the research and development of a technology or compound, resulting in a product which can be commercialized. In this situation, the licensing agreement governs who has permission to commercialize and what payments are due should commercialization proceed.

Other forms of licensing such as sub-licensing and cross-licensing are also explored, with examples provided together with listing of recent deals in pharma, biotech and diagnostics.

The report provides a detailed understand and analysis of how and why companies enter licensing deals. The majority of deals are multicomponent whereby the licensee retains either a right or option to license to commercialize the resultant product of the research collaboration. There are also numerous pure licensing deals whereby the products originator takes on a development/commercialization partner in order to maximize a technologies/products prospects.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all licensing deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of licensing deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in licensing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of licensing deals. The chapter includes numerous case studies to enable understanding of both pure licensing deals and multicomponent deals where collaborative R&D forms a part.

Chapter 4 provides a review of the leading licensing deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a review of the top 50 most active biopharma companies in licensing. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 6 provides a comprehensive review of licensing financials for deals announced since 2014, including headline value, upfront, milestone payments and royalty rates, providing both benchmark data and access to individual deal financials.

Chapter 7 provides a comprehensive and detailed review of licensing deals signed and announced since 2014 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.

The report also includes numerous table and figures that illustrate the trends and activities in licensing deal making since 2014.

In addition, a comprehensive appendix is provided organized by licensing company A-Z , stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about licensing partnering in the research, development and commercialization of technologies and products.

Key benefits

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 provides the reader with the following key benefits:

In-depth understanding of licensing partnering deal trends since 2014
Analysis of the structure of licensing agreements with numerous real life case studies
Comprehensive listing of over 4,500 licensing deals since 2014, together with deal terms, value and press release
Comprehensive access to actual licensing contracts entered into by the world’s life science companies
Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
Insight into the terms included in a licensing agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading life science companies worldwide.

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 includes:

Trends in licensing dealmaking in the biopharma industry since 2014
Analysis of licensing deal structure
Case studies of real-life licensing deals
Comprehensive listing of over 4,500 licensing deals since 2014
Access to licensing contract documents
Key financial bnchmarks for headline, upfront, milestone and royalty rates
The leading licensing deals by value since 2014
Most active licensing dealmakers since 2014
The leading licensing partnering resources

In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals and contracts are listed by:

Company A-Z
Headline value
Therapeutic area
Technology type

Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 report provides comprehensive access to available contract documents for licensing deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How do milestone align with clinical stage development phases?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

'

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in licensing deal making

2.1. Introduction
2.2. Definition of licensing deals
2.3. Success factors for licensing deals
2.4. When licensing can be useful
2.5. Attributes of licensing deals
2.6. Trends in licensing deals since 2014
2.6.1. Licensing deal making by year since 2014
2.6.2. Licensing deal making by phase of development since 2014
2.6.3. Licensing deal making by industry sector since 2014
2.6.4. Licensing deal making by therapy area since 2014
2.6.5. Licensing deal making by technology type since 2014
2.6.6. Licensing deal making by most active company since 2014
2.7. Option to license
2.8. Adding co-promotion to the mix
2.9. The future of licensing deals

Chapter 3 – Overview of licensing deal structure

3.1. Introduction
3.2. Pure versus multi-component licensing deals
3.3. Pure licensing agreement structure
3.3.1. Example licensing agreements
3.3.1.a. Case study 1: Ignyta – Nerviano Medical Sciences
3.3.1.b. Case study 2: Sanofi - Pozen
3.4. Licensing rights as part of a wider alliance agreement
3.4.1. Example licensing clauses
3.4.1.a. Case study 3: 4D Molecular Therapeutics – UniQure
3.4.1.b. Case study 4: Kyowa Hakko Kirin – Ultragenyx Pharmaceuticals
3.4.2. Example licensing option right clauses
3.4.2.a. Case study 5: Forest Laboratories - Trevena
3.4.2.b. Case study 6: Abbvie – Receptos

Chapter 4 – Leading licensing deals

4.1. Introduction
4.2. Top licensing deals by value

Chapter 5 – Top 25 most active licensing dealmakers

5.1. Introduction
5.2. Top 25 most active licensing dealmakers

Chapter 6 – Licensing deal term financials

6.1. Introduction
6.2. Licensing partnering headline values
6.3. Licensing deal upfront payments
6.4. Licensing deal milestone payments
6.5. Licensing royalty rates

Chapter 7 – Licensing contract directory since 2014

7.1. Introduction
7.2. Licensing deals with contracts since 2014

Appendices

Appendix 1 – Licensing dealmaking by companies A-Z
Appendix 2 – Licensing dealmaking by industry sector
Appendix 3 – Licensing dealmaking by stage of development
Appendix 4 – Licensing dealmaking by therapy area
Appendix 5 – Licensing dealmaking by technology type

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

TABLE OF FIGURES

Figure 1: Definition of licensing
Figure 2: Situations where licensing can prove useful
Figure 3: Key attributes of a licensing deal
Figure 4: Trends in licensing deal announcements since 2014
Figure 5: Licensing deals signed at each phase of development since 2014
Figure 6: Licensing deals by industry sector since 2014
Figure 7: Licensing deals by therapy area since 2014
Figure 8: Licensing deals by technology type since 2014
Figure 9: Top 25 most active licensing dealmakers sinnce 2014
Figure 10: Licensing agreements – what should a contract include?
Figure 11: Components of the licensing deal structure
Figure 12: Top licensing deals by value since 2014
Figure 13: Most active licensing dealmakers since 2014
Figure 14: Licensing deals with a headline value
Figure 15: Licensing deals with an upfront value
Figure 16: Licensing deals with a milestone value
Figure 17: Licensing deals with a royalty rate value

2A, 2bPrecise, 2M, 2X Oncology, 3-V Biosciences, 3B Pharmaceuticals, 3M, 3M Drug Delivery Systems, 3P Biopharmaceuticals, 3SBio, 4D Molecular Therapeutics, 4SC, 5LINX, 8E6Tong, 48Hour Discovery, A&B Company, A*STAR Agency for Science, Technology and Research, A1 Group, AADi, AAVLife, Abba Import Export, AB Biosciences, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, AbCellera, AbCheck, AbClon, Abcuro, Ab E Discovery, Abeona Therapeutics, Abic Marketing, Abide Therapeutics, Ability Pharmaceuticals, Ab Initio, Abiogen Pharma, Abiomed, ABL Bio, Ablexis, Ablynx, AbMed, Abpro, Absorption Systems, Abveris, ABX, Abyrx, Abzena, Acacia Research, ACADIA Pharmaceuticals, Acasti Pharma, Accellta, Accera Pharmaceuticals, Access Pharmaceuticals, Accord Healthcare, Acelity, Acella Pharmaceuticals, Acer Therapeutics, Acerus, Acetylon Pharmaceuticals, Achieve Life Science, Achillion Pharmaceuticals, AC Immune, Aclaris Therapeutics, Acorda Therapeutics, Acoustic MedSystems, Actavis (acquired by Watson), Actavis (name changed to Allergan), ACT Biotech, Actelion, Acticor Biotech, Actinobac Biomed, Active Biotech, ActiveSite, ActLight, Actuated Cardio Engineering, Actuated Medical, Acucela, Acumen Pharmaceuticals, Acura Pharmaceuticals, Acutus Medical, Adagene, AdAlta, Adama, Adamis Pharmaceuticals, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adapt Pharma, Adare Pharmaceuticals, Adarza BioSystems, ADC Therapeutics, Addex Therapeutics, Adept Neuro, Adhesys Medical, Adimab, Adlai Nortye, Adocia, Aduro BioTech, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced Biological Laboratories, Advanced BioMatrix, Advanced Catheter Therapies, Advanced Dosage Forms, Advanced Medical Solutions, Advanced Nuclear Medicine Ingredients, Advanced Proteome Therapeutics, Advance Pharmaceutical, Advanz Pharma, Advaxis, Adverum Biotechnologies, Aegerion Pharmaceutical, Aegis Therapeutics, Aelan Cell Technologies, Aeras, Aerial BioPharma, Aerie Pharmaceuticals, Aerogen, Aerpio Therapeutics, AEterna Zentaris, Aethlon Medical, Aevi Genomic Medicine, AffaMed Therapeutics, Affibody, Affilogic, Affimed Therapeutics, Affinivax, Affymetrix, AFT Pharmaceuticals, Agalimmune, AGC Asahi Glass, Agensys, Agenus Bio, Agilis Biotherapeutics, Agios Pharmaceuticals, AgomAb Therapeutics, Agricultural Research Service, AGTC, AiCuris, AIMM Therapeutics, AirWare Labs, AIT Therapeutics, AiVita Biomedical, Akaal Pharma, Akari Therapeutics, AkaRx, Akcea Therapeutics, Akebia Therapeutics, Akero Therapeutics, Akeso Biopharma, Akili Interactive Labs, Akonni Biosystems, Akorn, Akouos, Akrevia Therapeutics, Akriveia Therapeutics, Albany Molecular Research, Albert Einstein College of Medicine, Albion, Alcon Laboratories, Alcyone Lifesciences, Alder Biopharmaceuticals, Aldevron, Aldeyra Therapeutics, Alector, Aleva Neurotherapeutics, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfasigma, Aligo, Alimentary Health, Alimera Sciences, AliveCor, Alive Sciences, Alivio Therapeutics, Alize Pharma, ALK-Abello, Alkahest, Alkermes, Allakos, AllCells, Allegro Ophthalmics, Allele Biotechnology and Pharmaceuticals, Allergan, AllerGenis, Allergopharma, Alliance BioEnergy Plus, Alliance Pharma, Allied-Bristol Life Sciences, Allied Minds, Alligator Bioscience, Allogene Therapeutics, Alloksys Life Sciences, Almirall, Alnylam Pharmaceuticals, Alphaeon, Alphamab, Alpine Immune Sciences, ALS Biopharma, Altamira Pharma, Altan Pharma, Alteogen, Altor BioScience, Altum Pharmaceuticals, Altus Formulation, Alvit LCS Pharma, Alvogen, Alvotech, Alzamend Neuro, Alzyn, Amag Pharmaceuticals, Amarantus BioSciences, Amarillo Biosciences, Amarin, Ambrx, Ambys Medicines, AMD Insight, Amegabiotech, Amendia, Amend Surgical, American Cancer Society, American CryoStem, American Speech-Language-Hearing Association, Amfora, Amgen, Amherst Pharmaceuticals, Amneal Pharmaceuticals, AMO Pharma, AmorChem, Amorsa Therapeutics, AmplyCell, AMR, Amsel Medical, Amunix, AnaBios, Anacor Pharmaceuticals, Anagenesis Biotechnologies, Anahit, Analytical Testing Laboratory, AnaptysBio, Anatara Lifesciences, Anavex Life Sciences, Andor Pharmaceuticals, Angelini Pharma, AnGes MG, Angiochem, Angiocrine Bioscience, Angiodynamics, Angion Biomedica, Angionetics, AngioSoma, Angiostem, AnHeart Therapeutics, Anika Therapeutics, Anima Biotech, ANI Pharmaceuticals, Anixa Biosciences, Anji Pharma, Annias Immunotherapeutics, Ansell, Antengene, Anthera Pharmaceuticals, Anthos Therapeutics, Antibe Therapeutics, Antibody Solutions, Antigen Express, Antisense Therapeutics, Antitope, AntriaBio, Apceth, APC Therapeutics, Apeiron Biologics, Aperion Biologics, Apexigen, Aphria, Aplagon, Apogenix, ApolloBio, Apotex, Appello Pharmaceuticals, Appili Therapeutics, Applied BioCode, Applied Biology, Applied DNA Sciences, Applied Molecular Transport, Applied StemCell, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apricus Biosciences, APRINOIA Therapeutics, Apsen Farmacutica, AptaBio Therapeutics, Aptarion biotech, Aptinyx, Aptose Biosciences, Aquinox Pharmaceuticals, Aragen Bioscience, Aralez Pharmaceuticals, Aratana Therapeutics, Arbele, Arbor Biotechnologies, ArborGen, Arbutus, Arcadia Biosciences, ArcDia, Arch Biopartners, ArcherDX, Arcis Biotechnology, Arcoral Pharma, ArcticDx, Arcturus Therapeutics, Arcus Biosciences, Arcutis, Ardelyx, Arena Pharmaceuticals, Ares Genetics, arGEN-X, Argentum Pharmaceuticals, argenx, Argon Medical Devices, Argos Therapeutics, Ariad Pharmaceuticals, Aridis Pharmaceuticals, Ariosa Diagnostics, Aristea Therapeutics, Arjuna Naturals, Ark Biosciences, ArmaGen, Armetheon, ARMO Biosciences, Arno Therapeutics, Aro Biotherapeutics, ArQule, Arradiance, Arrakis Therapeutics, Array Biopharma, Arrien Pharmaceuticals, Arrowhead Pharmaceuticals, Arrow Pharmaceuticals, Arrys Therapeutics, Arsanis Biosciences, Artelo Biosciences, Arthrex, Aruvant Sciences, Arvelle Therapeutics, Arvinas, Asahi Kasei, Asana Biosciences, Asana Medical, Ascendance Biotechnology, Ascenion, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, Aseptix, Asieris MediTech, ASKA Pharmaceuticals, AskAt, AS Kevelt, Asklepios Biopharmaceutical, Aslan Pharma, Aspen Holding, Aspen Park Pharmaceuticals, Aspen Pharmacare Canada, Aspire Health Science, Aspyrian Therapeutics, Assembly Biosciences, Astellas Pharma, Astellas Pharma Europe, Asterias Biotherapeutics, AstraZeneca, Astute Medical, Asymptote, Atara Biotherapeutics, Athenex, Athersys, Atlante Biotech, Atlantic Healthcare, Atopix, Atossa Genetics, ATUM, Atvio Biotech, Aucta Pharmaceuticals, Audentes Therapeutics, Audion Therapeutics, AUM Biotech, Aura Biosciences, Auransa, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Aurobindo Pharma, Aurora Cannabis, Australian Research Council, Austrianova Singapore, Autifony Therapeutics, Autolus, Automation Anywhere, Autotelic, Auven Therapeutics, Auxly Cannabis Group, Auxogyn, Avacta, Avactis Biosciences, Avadel Pharmaceuticals, Avalanche Biotechnologies, Avalon GloboCare, Avaria Health & Beauty, Avenue Therapeutics, AVEO Oncology, AveXis, Avidity Biosciences, Avillion, Avion Pharmaceuticals, Aviragen Therapeutics, Avrobio, Axcelead Drug Discovery Partners, AXIM Biotechnologies, Axiogenesis, Axiom Worldwide, Axis Therapeutics, AxoSim, Axovant Sciences, Axxam, Axxess Pharma, Ayala Pharmaceuticals, Aytu BioScience, Azaya Therapeutics, Aziyo Biologics, AzurRx BioPharma, Back-A-Line, Back Bay Scientific, Bactevo, Baker IDI Heart and Diabetes Institute, Banyan Biomarkers, Basilea Pharmaceutica, BAS Research, BATM, Battelle, Batu Biologics, Bausch & Lomb, Bavarian Nordic, Baxalta, Baxter International, Bayer, Bayer Animal Health, Bayer CropScience, Bayer Healthcare, Bayer Schering Pharma, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Miraca Genetics Laboratories, BayPAT, Bazelet, BB100, BDD Pharma, Beacon Discovery, Beactica, Beam Therapeutics, Beckman Research Institute of City of Hope, Becton Dickinson, BeiGene, Beijing SL Pharma, Beijing Strong Biotechnologies, Beike Biotech, Bellerophon Therapeutics, Bellicum Pharmaceuticals, Bellus Health, Bened Biomedical, BenevolentAI, Benitec Biopharma, Benson Hill Biosystems, Berkeley Lights, Berlin Chemie, Bertech Diagnostics, Besins Healthcare, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, BexPharm, BGN Technologies, Bhang, BHV Pharmaceuticals, Bial, Bicycle Therapeutics, Biedermann Motech, Bill and Melinda Gates Foundation, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, BioAlliance Pharma, BioArctic Neuroscience, biOasis Technologies, BioAtla, BioBlast Pharma, BioCardia, Biocare Medical, Biocept, Bioceros, BiocerOX Products, Biocodex, Biocon, BioCorRx, Biodel, BioDelivery Sciences, Bio DG, Biodirection, BioDlogics, BioDuro, Bio Farma, BioGaia, Biogen, BioGenetics, Bioharmony Therapeutics, Biohaven Pharmaceutical Holding, BioHeart, BioInvent, Bioject Medical Technologies, BioLamina, BioLegend, BiolineRX, Biolin Scientific, Biologix FZCo, BioMarin Pharmaceutical, Biomatrica, Biomed, Biomedical Advanced Research and Development Authority, Biomerica, Biomerics, bioMerieux, Biomunex Pharmaceuticals, BiomX, Bioneer, Bionomics, BioNovion, Bionovus Life Sciences, BioNTech, Bionure, BionX Medical Technologies, Bioo Scientific, Bio Palette, BioPharma Forest, BioPhausia, BioPorto, Bioprojet, Bioptic, BioQ Pharma, BioRap Technologies, BioReliance, Biosearch Technologies, BioSense Global, BioSilta, Biosynth, Biotectix, Biotest, BioTheryX, Biotheus, BioTime, Biotoscana Farma, BioVaxys, Bioventus, Bioverativ, BioWa, BioXcel, BirchBioMed, Bird Foundation, Birdie Biopharmaceuticals, Biscayne Neurotherapeutics, BL&H, Blackford, Blackrock Microsystems, BlackThorn Therapeutics, Blacktrace Holdings, BlinkBio, BliNK Biomedical, Bliss Biopharmaceutical, Bloom Science, Bluebird Bio, Bluechiip, BlueOcean Nutrascience, Blueprint Medicines, BlueRock Therapeutics, Blue Sky Biotech, Bluestar Alliance, Blue Water Vaccines, BMV Medica, BODIMETRICS, Body Labs, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bone Biologics, Bone Therapeutics, Bonutti Skeletal Innovations, Bora Pharmaceuticals, Boryung Pharmaceutical, Bosch, Boston Pharmaceuticals, Boston Scientific, Boston Strategics, Boston Therapeutics, Boston University, Botanisol, BoyaLife, Braeburn Pharmaceuticals, BrainLAB, BrainStorm Cell Therapeutics, Branhaven, BravoVax, Breathe Active, Breathe ECig, Breathtec BioMedical, Breath Therapeutics, Breckenridge Pharmaceuticals, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Brigham and Women's Hospital, Bright Future Pharmaceutical Lab, Brighton Biotech, Brii Biosciences, Brill Pharma, BRIM Biotechnology, Brink Biologics, Bristol-Myers Squibb, Broad Institute, BroadMed, Broda Technologies, Brown University, Bruker, BryoLogyx, BTG, BTS Research (BTS), Buck Institute for Age Research, Bugworks, Butantan Institute, Byrne Medical, C-Bridge Capital, C2N Diagnostics, C3i, C4 Therapeutics, C4X Discovery, Cadence Pharmaceuticals, Cadent, Cadila Pharmaceuticals, Caelum Biosciences, Caladrius Biosciences, Caliber Biotherapeutics, Calico, California Institute for Biomedical Research, California Institute for Quantitative Biosciences (QB3), California Institute of Technology, Calimmune, Calithera Biosciences, Calixar, Calliditas Therapeutics, Calox de Costa Rica, Calypso Biotech, Calyxt, Camarus, Cambridge Cognition, Cambridge Epigenetix, Cambridge Research Biochemicals, CamelBak, CAMP4 Therapeutics, Camurus, Can-Fite BioPharma, Canada House Wellness Group, CanBas, CANbridge Life Sciences, CancerLinQ, Cancer Prevention Pharmaceuticals, Cancer Research Technology, Cancer Research UK, Cancer Targeted Technology, Candela, Cannabis OneFive, CannaRoyalty, CannaSkin, CanniMed Therapeutics, CannScience Innovations, Canntab Therapeutics, Canopy Biosciences, Canopy Growth, Cantabria Pharma, Cantargia, Cantex Pharmaceuticals, CAO Pharmaceuticals, Capricor Therapeutics, Caprion Proteomics, Cara Therapeutics, Carbonics, Cardiff University, Cardinal Health, Cardinal Partners, Cardiome Pharma, CardioSert, Cardiowise, Cardurion Pharmaceuticals, Cargill, Caribou Biosciences, Carlos Slim Health Institute, Carmel Pharma, Carmot Therapeutics, Carna BioSciences, Carrick Therapeutics, Cascade Pure, Casebia Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, Casma Therapeutics, Castle Creek Pharmaceuticals, Catalent Pharma Solutions, Catalyst Pharmaceutical Partners, Catapult Therapy TCR, CavoGene LifeSciences, CB2 Therapeutics, CBT Pharmaceuticals, Ceapro, Cedars-Sinai Medical Center, Celdara Medical, Celgene, Celimmune, Celladon, Cell Care Therapeutics, Cell Design Labs, Celldex Therapeutics, Cellecta, Cellectar Biosciences, Cellectis, Cellectricon, Cellesce, CellGenix, Cell Guidance Systems, Celling Biosciences, Cell Medica, Cellmid, CellProThera, CellSight Technologies, Cell Source, Cell Therapy, Cell Therapy Catapult, Cellth Systems, Celltrion, Cellular Biomedicine, Cellular Dynamics International, Celonic, Celsee, Celsion, Celtic Biotech, Celtis Pharm, Celyad, Center for Cancer Research, Central Institute for Experimental Animals, Centre for Drug Design and Discovery, Centre for Drug Research and Development (CDRD), Centre For The Commercialization Of Antibodies And Biologics, Centrexion, Centro de Investigación Biomédica en Red de Salud Mental, Centurion, Cequr, Cereal Ingredients, Cerecor, Ceres, Cerevance, Certara, Certis, Cerveau Technologies, CEVA, Ceva Sante Animale, Cevec Pharmaceuticals, cGreen, Chameleon BioSurfaces, Changchun BCHT Biotechnology, Changshan Pharm, Chaperone Technologies, Charles River Laboratories, Charleston Laboratories, Chart Industries, CheckedUp, Checkmate Pharmaceuticals, CheckPoint Immunology, Checkpoint Therapeutics, Chembio Diagnostics, Chemesis, Chemi Pharmaceutical, ChemoCentryx, Chemstar, Chi-Med, Chiesi Farmaceutici, Children's Cancer Institute Australia for Medical Research, Children's Hospital Boston, Children's Hospital of Philadelphia, Chimerix, China Medical System, China National Biotech Group (CNBG), China Oncology Focus, China State Institute of Pharmaceutical Industry (CIPI), Chiome Bioscience, Chiromics, Chondrial Therapeutics, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, Chongqing Lummy Pharma, ChromaDex, Chroma Therapeutics, Chromocell, Chugai Pharmaceutical, Chugai Pharma Marketing, Cibus Global, Cilag AG, Cimtech, Cincinnati Children’s Hospital Medical Center, CinCor Pharma, Cinda Bio-Pharmaceutical, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Circassia, Circulogene, Cirle, Cisen Pharma, Citius Pharmaceuticals, Citron Pharma, City of Hope, CiVi Biopharma, CJ Corp, CJPS Healthcare Supplies & Equipment, Clal Biotech, Claremont BioSolutions, Clarity Pharmaceuticals, ClearLight Diagnostics, Clearside Biomedical, Clementia Pharmaceuticals, Cleveland Clinic, Cleveland Diabetes Care, Cleveland Diagnostics, Clevexel Pharma, Click Therapeutics, Clinical Genomics, Clinical Laserthermia Systems (CLS), Clinica Ruiz, Clinigen, Clontech Laboratories, Clover Therapeutics, CMC Biologics, CMS Medical, CNA Development, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Coapt, CoapTech, Cochlear, Cocoon Biotech, Cocrystal Pharma, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Cogentix Medical, Cognoa, Cold Spring Harbor, Collegium Pharmaceuticals, Collplant, Colorcon, Columbia Care, Columbia Laboratories, Columbia Technology Ventures, Columbia University, Comercializadora BioRenal, Commense, Common Sense, Compassionate Care Center of New York, Complix, Compugen, Conatus Pharmaceuticals, Concordia Healthcare, Concortis Biosystems, ConforMIS, Confo Therapeutics, Conmed, Consilient Health, ConsortiaTX, Contamac, Context Therapeutics, Contextual Genomics, ContraFect, ContraVir Pharmaceuticals, Convelo Therapeutics, Convergence Pharmaceuticals, ConverGene, Cook Biotech, Corbin Therapeutics, Corbus Pharmaceuticals, Cordis, Corestem, Corgenix Medical, Corino Therapeutics, Cornell University, Coronado Biosciences, Correvio, Corsair Pharma, Cortendo, Corteva Agriscience, Cortex Pharmaceuticals, Cortexyme, Cortice Biosciences, Corvidia Therapeutics, Corvium, Corvus Pharmaceuticals, Covalon Technologies, Covance, Covidien, Create Vaccine Company, Creative Medical Technologies, Crescendo Biologics, Crescita Therapeutics, Cresset, CRISPR Therapeutics, Critical Diagnostics, Critical Path Services, Crossbeta Biosciences, Crosscare, Crown Bioscience, Crown Laboratories, CR Pharma, CRT Pioneer Fund, Cryolife, Crystal Bioscience, CrystalGenomics, CSC Pharmaceuticals, CSIRO, CSL, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTC Bio, CTI BioPharma, CTT Pharmaceutical, CTX Technology, Cue Biopharma, Cullinan Oncology, Cumberland Pharmaceuticals, Cumulus Oncology, Curadev Pharma, CURE Pharmaceutical, Cures Within Reach, CureTech, Curetis, CureVac, Curis, Curium, CURx Pharmaceuticals, Cutanea Life Sciences, Cutting Edge Healthcare, CvergenX, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cycle Pharmaceuticals, Cyclopharm, Cygnus, CymaBay Therapeutics, Cynata Therapeutics, Cyndea Pharma, Cyntec, Cyon Therapeutics, Cypralis, Cypress Pharmaceutical, Cyrenaic Pharmaceuticals, Cytokinetics, CytoLumina Technologies, CytomX Therapeutics, Cytos Biotechnology, CytoSen Therapeutics, Cytovant Sciences, CytRx, D&A Pharma, D. Western Therapeutics Institute, Daewoong Pharmaceutical, Daiichi Sankyo, Dainippon Sumitomo Pharma, Daktari Diagnostics, Dalhousie University, Dana-Farber Cancer Institute, DARA BioSciences, Dare Bioscience, Dartmouth College, DarwinHealth, Dauntless Pharmaceuticals, Debiopharm, Dechra Pharmaceuticals, Decibel Therapeutics, Deciphera Pharmaceuticals, de Duve Institute, Defense Advanced Research Projects Agency, DefiniGEN, Defyrus, DEG Productions, Dekel Pharmaceuticals, Delcath Systems, Delivra, DelMar Pharmaceuticals, Delphi Genetics, DelSiTech, Delta 9 Cannabis, Demetrix, Denali Therapeutics, DendroCyte, Denka, Denka-KEW Genomics, Denovo Biopharma, Densitas, Densmore Pharmaceutical, Department of Veterans Affairs, DepoMed, Derma Sciences, Dermata Therapeutics, Dermavant Sciences, Dermelix Biotherapeutics, Dermira, Desktop Genetics, Destiny Pharma, DeuteRx, Dexcel Pharma, DexCom, diaDexus, DiagnoCure, Diagnovus, DiA Imaging Analysis, DiaMedica, DIAN Diagnostics, Diatheva, DiCE Molecules, Dicerna Pharmaceuticals, Diego Pellicer, Dignity Health, Dilafor, Dimension Therapeutics, DiNonA, Discuva, Distributed Bio, Dixi, DNA Script, DNAtrix, DolCas Biotech, Domain Therapeutics, Dong-A Pharmaceutical, Dong-A ST, Dorian Therapeutics, Dow AgroSciences, Dow Chemical, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dr. U Devices, Dragonfly Therapeutics, Dr Allen Wu, DreaMed Diabetes, DRI Capital, DSM, DSM Sinochem Pharmaceuticals, Dual Therapeutics, DuChemBio, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke University, DuPont, Durata Therapeutics, Durect, Dynacure, Dynamic Combinatorial Chemistry, Dynavax Technologies, E-Scape Bio, Eagle Genomics, Eagle Pharmaceuticals, EA Pharma, Eastern Cooperative Oncology Group, Easton Pharmaceuticals, EB Pharma, ECM Therapeutics, Ecolab, Ecole Polytechnique Federale de Lausanne, EcoPesticides, EDAP TMS, Eddingpharm, Edelris, Edinburgh Innovations, Edison Pharmaceuticals, Editas Medicine, Educational and Scientific, Edwards Lifesciences, EffRx, Egalet, EhmetDx, Eiger BioPharmaceuticals, Eiken Chemical, EIP Eczacibasi Ilac Pazarlama, EirGenix, EirGen Pharma, Eisai, Eisai Inc, Ekso Bonics, Elanco, Elasmogen, Elcelyx Therapeutics, Elekta, Eleven Biotherapeutics, Elexopharm, Eli Lilly, Elis Pharmaceuticals, Elite Pharmaceuticals, Elixirgen, Elpis Biomed, ElsaLys Biotech, Eltima Software, Elysium Health, EmboMedics, Emcure Pharmaceuticals, EMD Millipore, EMD Serono, Emendo Biotherapeutics, Emerge Health, Emergent BioSolutions, Emergex Vaccines, Emisphere, Emmaus Life Sciences, Emory University, EMS, Encore Dermatology, Endocanna Health, EndoCeutics, Endocyte, Endo International, EndoLogic, Endo Pharmaceuticals, Endo Ventures, enGene, EnGeneIC, Enigma Biomedical, Enlibrium, Ensemble Therapeutics, Entasis Therapeutics, Entera Health, Enteris Biopharma, Enterome Bioscience, Enterprise Partners Venture Capital, Enthera, Entos Pharmaceuticals, Entrinsic Health Solutions, Enumeral Biomedical, EnWave, ENYO Pharma, Enzymotec, Eolas Therapeutics, EOS Imaging, Epic Pharmaceuticals, EpiDestiny, Epigen Biosciences, Epigenomics, EpimAb Biotherapeutics, Epirus Biopharmaceuticals, Epivax, Epizyme, Ergomed, ERS Genomics, ES Cell International, Especificos Stendhal, EspeRare Foundation, Esperion Therapeutics, Espero Pharmaceuticals, Establishment Labs, Esteve, Eton Pharmaceuticals, Eucodis Bioscience, Eu Hwa, Eureka Therapeutic, Eurofarma, Eurofins Genomics, Eurofins Scientific, Euroimmun, European Commission, European Equity Partners, EUSA Pharma, Eutilex, Evecxia, Evelo Biosciences, Event Cardio Group, Everest Medicines, Evestra, Evolva, Evonik Industries, Evotec, Evox Therapeutics, Ewopharma, Exact Sciences, Excelimmune, Excelra, Excision BioTherapeutics, Exelixis, Exeltis, Exicure, Exiqon, Exonics Therapeutics, ExoStat Medical, Exovita Biosciences, Expedeon, ExpreS2ion Biotechnologies, ExScientia, Exzell Pharma, Eyegate Pharmaceuticals, Eyeon Therapeutics, EyePoint Pharmaceuticals, Eyevance, F-Star, F1 Oncology, F2G, FAAH Pharma, Facit, Faes Farma, Fagron, Famy Care, Fate Therapeutics, Fedora Pharmaceuticals, Feldan Therapeutics, Femtogenix, Ferrer International, Ferring Pharmaceuticals, FetoLumina Technologies, FGH Biotech, Fibriant, Fibrocell Science, Fibrocor Therapeutics, Fibrogen, Fidia Farmaceutici, Fina Biosolutions, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., Five Prime Therapeutics, FKD Therapies, Flamel Technologies, Flexion Therapeutics, FloDesign Sonics, Florida State University, Flower One, Flow Pharma, Fluicell, Fluidigm, Fluoresentric, Flynn Pharma, FOB Synthesis, Fondazione San Raffaele, Fondazione Telethon, Food and Drug Administration (FDA), Forage Genetics, Forendo Pharma, Foresee Pharmaceuticals, Forge Therapeutics, Formac Pharmaceuticals, FORMA Therapeutics, Fortify Therapeutics, Fortress Biotech, Forty Seven, Forward Pharma, Fosun Pharmaceutical, Foundation for Celiac Disease Outcome Measures, Foundation Medicine, Fraunhofer Institute for Microelectronic Circuits and Systems, Fraunhofer Institute for Molecular Ecology (IME), Fred Hutchinson Cancer Research Center, Freedom Leaf, Frequency Therapeutics, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Frontier Biotech, Front Range Biosciences, Fscan, FSD Pharma, Fudan University, Fuhong Hanlin, Fujifilm, Fujifilm Kyowa Kirin Biologics, Fujifilm Pharma, Fuji Pharma, Fujirebio Diagnostics, Fulcrum Therapeutics, Fundacion Medina, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Pharmaceuticals, FuturaGene, G-treeBNT, G2B Pharma, G3 Pharmaceuticals, Gadeta, Gaia BioPharma, Galapagos, Galaxy Biotech, Galderma, Galen, Galena Biopharma, Galmed Pharmaceuticals, GamaMabs Pharma, Gan & Lee, GB Sciences, GCA Therapeutics, GC LabCell, GC Pharma, Gebro Pharma, Gedeon Richter, GE Healthcare, Gemphire, Gen-Probe, GEn1E Lifesciences, Gen9, Genable Technologies, Genagon Therapeutics, GenAhead Bio, Genco Sciences, GeneBay, Gene Biotherapeutics, Genective, GeneData, Geneia, GeneNews, Genentech, Geneos Therapeutics, GeneQuine Biotherapeutics, General Biologicals, Generex Biotechnology, Genesee BioMedical, GeneSeek, Genethon, Genetic Analysis, Genetic Immunity, Genetic Information Research Institute, Genetic Technologies, GeNeuro, Genevant Sciences, Genexine, Genfit, Genisphere, Genmab, GenoDive Pharma, GenoLogics, Genomic Health, Genomic Vision, genOway, GenStem Therapeutics, Genticel, Genus, GenVec, Genzyme, Georgetown University, George Washington University, Georgia State University, Georgia State University Research Foundation (GSURF), German Cancer Research Center, Geron, Gestion Univalor, Gestvision, GID Group, Gilead Sciences, Glaukos, GlaxoSmithKline, GlaxoSmithKline Biologicals, Glenmark Pharmaceuticals, Glide, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Diagnostics, Global Drug Development Centre (GDCC) China, Global Orthopaedic Technology, Globavir Biosciences, GlycoBac, Glycocept, Glycotope Biotechnology, Glycyx Pharmaceuticals, Glythera, Gnosis Bioresearch, GNS Healthcare, Gold Coast Therapeutics, Goldfinch Bio, Goliver Therapeutics, Good Start Genetics, Goodwin Biotechnology, Google, Gossamer Bio, GO Therapeutics, Gour Medical, Grace Bio-Labs, Grail, Gravocore, GrayBug, Greatbatch, Great Belief International, Grenco Science, Grid Therapeutics, Grifols, Gritstone Oncology, Grunenthal, Grupo Ferrer, Grupo Juste, GTx, Guangzhou Xiangxue Pharmaceutical, Gubra, Guided Therapeutics, Guilin Pharmaceutical, Gynial, Gyros Protein Technologies, H&P Labs, H3 Biomedicine, Hadasit Bioholdings, Hadasit Medical Research Services and Development, Haibo Biotechnology Institute, Hainan Sinotau Pharmaceutical, Hairmore Group, Haisco Pharmaceutical, HalioDx, Halozyme Therapeutics, Halt Medical, Halyard Health, Hamad Medical, Hamamatsu Photonics, Hammock Pharmaceuticals, HanAll Pharmaceuticals, Hancock Jaffe Laboratories, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hannover Medical School, HanX Biopharmaceuticals, Hao Le Ku (Beijing) Infant And Maternity, Haplogen, HAPPYneuron, Hapten Sciences, Harbin Gloria Pharmaceuticals, Harbour Antibodies, Harbour Biomed, Harmony Biosciences, Harpoon Medical, Harpoon Therapeutics, Harvard Medical School, Harvard University, Hatch Medical, Hatchtech, Healeon Medical, Healios K.K., Health Canada, Healthcare Global Enterprises, HealthLytix, HealthMyne, HealthPointe Solutions, Health Sciences Research Institute Germans Trias i Pujol Foundation, Healthy Focus, Healthy Grain, HeartHero, Heart Imaging Technologies, Heat Biologics, HEC Pharm, Hefei Life Science, Hefei Tianhui Incubation of Technologies, Heidelberg Pharma, Helen F Graham Cancer Center, Helius Medical Technologies, Helix BioPharma, Helmholtz Zentrum Munchen, Helsinn Healthcare, Helsinn Therapeutics, HemispheRx Biopharma, HemoCleanse, Hemogenomics Pharma, Hemogenyx, HemoShear, Hemostemix, Henlius Biotech, Hennig, Henry Ford Health System, Heraeus, HerbalScience Group, Hetero Labs, Heumann Pharma Generics, HiberGene Diagnostics, HiFiBio, Highland Pharmaceutical, Hikma Pharmaceuticals, Hill Dermaceuticals, Histocell, Histogen, Histogenics, Histogen Oncology, HitGen, HLS Therapeutics, Hoffmann La Roche, HoliStick Medical, Hologic, HoMedics, Homology Medicines, Honeywood, Hongene Biotechnology, Hong Kong Polytechnic University, Honor, Hookipa Biotech, HOPE BIOSCIENCES, Hope Medicine, Horizon Discovery, Horizon Pharma plc, Horus Pharma, Hospira, Hoth Therapeutics, Hough Ear Institute, Hovione, Hsiri Therapeutics, HSRx Group, Huapont Pharma, Hubrecht Organoid Technology, Humabs BioMed, Humacyte, Human Life CORD Japan, Human Longevity, Huntsman Cancer Institute, HUYA Bioscience, Hydra Biosciences, HydroCision, Hyundai Pharmaceutical, I-mab, IACTA Pharmaceuticals, IBC Generium, iBio, Icagen, Icahn School of Medicine at Mount Sinai, ICB Pharma, Ice + Jam, Ichor Medical Systems, ICL, ICM, Iconic Therapeutics, iDD Biotech, IDEAYA Biosciences, Idengene, Idera Pharmaceuticals, IDIBELL, Idorsia, ID Pharma, IDT, Igenica, Ignyta, Iksuda Therapeutics, Ildong Pharmaceutical, ILiAD Biotechnologies, Illumina, ILTOO Pharma, ImaginAb, Imago Pharmaceuticals, Imanis Life Sciences, Imanova, Imaxio, Imbrium Therapeutics, ImClone Systems, Imcyse, iMetabolic Biopharma, Immatics Biotechnologies, ImmBio, Immugenyx, ImmuMetrix, Immune-Onc Therapeutics, Immune Biosolutions, Immune Design, Immune Pharmaceuticals, ImmuNext, ImmunGene, Immunitor, ImmunoBiochem, ImmunoCellular Therapeutics, ImmunoChina Pharmaceuticals, Immunocore, ImmunoForge, ImmunoGen, ImmunogenX, Immunomedics, Immunomic, ImmunoQure, Immunovaccine, Impax Laboratories, Imperial Brands, Imperial Innovations, Impopharma, Impression Healthcare, Imprimis Pharmaceuticals, Imricor Medical Systems, Imugene, IMV, In-Vivo Science International, Inari Medical, IncellDx, Inception Sciences, INC Research, Incyte, InDevR, InDex Pharmaceuticals, Index Ventures, Indiana University, Indivior, Induce Biologics, Inexia, Infinity Pharmaceuticals, Infirst HEALTHCARE, InflamaCORE, Inflection Biosciences, Inhibitor Therapeutics, Inhibrx, INmune Bio, Innate Pharma, InnerOptic Technology, InnerScope Hearing Technologies, Innocutis, Innova Biosciences, Innovare, Innovasource, Innovate Biopharmaceuticals, Innovate UK, Innovation Network Corporation, Innovation Pharmaceuticals, Innovative Cellular Therapeutics, Innovent Biologics, Innovet, Innovus Pharmaceuticals, INO Therapeutics, Inova Diagnostics, Inovio, Inovio Pharmaceuticals, InQpharm, Inserm, Inserm Transfert, Insight Genetics, Insightra Medical, Insilico, InSite Vision, Insitro, Insmed Inc, Inspirion Delivery Sciences, InspiRX Pharma, Institut Curie, Institute for Myeloma and Bone Cancer Research, Institute of Biophysics, Institute of Cancer Research, Institute of Crop Sciences, Institute of Genetics and Molecular and Cellular Biology, Institute Of Molecular Biotechnology, Institute of Natural Fibres and Medicinal Plants, Institut Gustave Roussy, Institut Pasteur, Insulet, Insys Therapeutics, Intarcia Therapeutics, Intec, IntegraGen, Integra LifeSciences, Integrated Animal Health, Integrated BioTherapeutics, Integrated Cannabis Company, Integrated Diagnostics, Integrated DNA Technologies, Integrity Implants, Integrity Life Sciences, IntelGenx, Intellia Therapeutics, IntelliCell BioSciences, Intellipharmaceutics, Intellirod Spine, Interleukin Genetics, International Hemp Solutions, International Medica Foundation, International Partnership for Microbicides, International Stem Cell, InteRx Biomedical, Intratus, Intravacc, Intrexon, iNtRON Biotechnology, Intuitive Surgical, Invenra, InvenSense, InventisBio, Inventiva, inVentiv Health, Invigorcell, Invion, InVivo, InVivoScribe, INVO Bioscience, Ion Channel Innovations, Ionis Pharmaceuticals, IONTAS, Iovance Biotherapeutics, Ipca Laboratories, iPharma, iPS Academia Japan, Ipsen, Iroko Pharmaceuticals, Iron Horse Diagnostics, Ironwood Pharmaceuticals, ISA Pharmaceuticals, Isarna Therapeutics, ISIS Innovation, Islet Sciences, Isogenica, IsoPlexis, Isoprene Pharmaceuticals, Isotope Technologies Garching, Israeli National Authority for Technological Innovation, Italfarmaco, Item, iTeos Therapeutics, ITM Isotopen Technologien, Itonis, Itus, Iveric Bio, IXICO, Izana Bioscience, J&H, Jackson Laboratory, Jacksonville Pharmaceuticals, Jacobson Pharma, Jaguar Health, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janssen Sciences, Japan Tobacco, Jazz Pharmaceuticals, JCR Pharmaceuticals, JenKem Technology, Jerome Stevens Pharmaceuticals, JHL Biotech, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Egens Biotechnology, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu NHWA Pharmaceutical, Jianshun Biosciences, Jing Medicine, Jinzhou Ahon Pharma, Jitsubo, Jnana Therapeutics, John Morley Foods, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Jounce Therapeutics, JSC Pharmadis, JSR, Jubilant DraxImage, Juniper Pharmaceuticals, Juno Therapeutics, Just Biotherapeutics, JustRight Surgical, Juvenescence, Juventas Therapeutics, JW Pharmaceutical, K2M, Kadimastem, Kadmon Pharmaceuticals, Kaken Pharmaceutical, Kaldi Pharma, Kalgene Pharmaceuticals, Kallyope, KaloBios Pharmaceuticals, KalVista Pharmaceuticals, Kalytera Therapeutics, Kamada, Kane Biotech, Kaneka, KannaLife Sciences, karmadata, Karyopharm Therapeutics, Kastle Therapeutics, Kazusa DNA Research Institute, KDAc Therapeutics, Kelun-Biotech Biopharmaceutical, KemPharm, Keryx Biopharmaceuticals, KEW, Keystone Heart, KFx Medical, Khandelwal Laboratories, KineMed, Kineta, Kinetic Concepts, Kinex Pharmaceuticals, Kings College London, Kirin, Kissei Pharmaceutical, Kite Pharma, Kitov, Klaria, KLOX Technologies, Klue, Knighton Foods, Knight Therapeutics, KNOW Bio, Knudra Transgenics, Kobe University, KODE Biotech, Kodiak Sciences, Kogenix, Kolltan Pharmaceuticals, Kolon Life Science, KoRa Healthcare, Koushan Pharmed, Kowa, Kowa Pharmaceuticals America, Kuhnil Pharmaceuticals, Kunming Pharmaceutical, Kura Oncology, Kurve Technology, KVK-Tech, Kwang Dong Pharmaceutical, Kwangdong Pharmaceutical, KWS SAAT, Kymab, Kymera Therapeutics, Kyn Therapeutics, Kyorin Pharmaceutical, Kyoto University, Kyowa Hakko Kirin, Kythera Biopharmaceuticals, L&F Research, Labcon, labfolder, Laboratoires Thea

$2,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports